Access cutting-edge leptomeningeal metastasis treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access leptomeningeal metastasis specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related leptomeningeal metastasis treatment provided free
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effective
Sponsor: NRG Oncology
Check if you qualify for this leptomeningeal metastasis clinical trial in Little Rock, AR
If you're searching for leptomeningeal metastasis treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced leptomeningeal metastasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.